IMO

Details for Australian Trade Mark No. 1001421 (hide)

Owner Idera Pharmaceuticals

Convention US 22 July 2003 78/277.138

Service Davies Collison Cave

Filing Date 22 January 2004

Classes

Class 5 Immunomodulatory oligonucleotides, namely ingredients that enhance or induce an immune response in a pharmaceutical preparation; none of the foregoing being used for the treatment of idiopathic multicentric osteolysis

Event Publications

30 March 2006 Application Accepted

27 July 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1001422-INDIVIDUAL COMPACT DISC

1001420-PROACTIV SOLUTION